Delivery Order SPE2DB22D1202-SPE2DB25FVJK0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $6,235.76 for NURTEC ODT 75 MG tablets (8-count) on December 2, 2025, with completion scheduled for December 3, 2025. This competitive, non-set-aside award reflects a firm fixed price contract for pharmaceutical delivery to support federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) with a contract ceiling value of $7,416.21. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $31,949.98 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 1, 2025, with completion scheduled for December 2, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,446.64 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $5,850.24. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for ultimate completion on November 17, 2025. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $14,675.36. This firm fixed-price delivery order, awarded on June 30, 2025, with a completion date of July 1, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count) with a contract ceiling value of approximately $20.2K. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) with a ceiling value of $12,688.65. This firm fixed-price delivery order, which is expected to be completed by September 18, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of NURTEC ODT 75 mg tablets (8 count). This is a firm fixed price delivery order with a ceiling value of $11,327.55 and an ultimate completion date of November 4, 2025. The award was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVJK0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $5,859.08. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a competitive award with no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its substantial role as a critical vendor for Department of Defense medical procurement, supplying specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/26/25 |